Disopyramide and Lumefantrine: Interaction Details

Brand names
Disopyramide
NorpaceNorpace CR
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Lumefantrine

We don't have a separate drug information page for Lumefantrine. The FDA's drug directory lists it as part of Coartem (artemether and lumefantrine). Read the Artemether and Lumefantrine drug information page → Have a question about Lumefantrine? Ask a pharmacist, free →

Disopyramide

Brand names
  • Norpace
  • Norpace CR

What Happens When You Take Disopyramide With Lumefantrine

What can happen when they are taken together (rated Major)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because may lengthen the , artemether/lumefantrine should not be given together with QT-prolonging drugs such as disopyramide. When combining artemether/lumefantrine with a QT-prolonging agent cannot be avoided for medical reasons, monitoring is warranted.

Lumefantrine also has a long (3 to 6 days), so care should be taken when QT-prolonging drugs are started after a course of artemether/lumefantrine has been completed.2 Should the QT interval lengthen by more than 25% in the presence of persistent ectopy, the patient requires close monitoring, and stopping disopyramide should be considered.1

The Disopyramide and Lumefantrine Interaction, Explained

Lumefantrine is a malaria medicine (usually given together with artemether), and disopyramide (Norpace) is a heart rhythm medicine. Both can affect the heart's electrical recharge time, called the . Taken together, the effects may add up and raise the chance of a serious irregular heartbeat.

This concern is based on how the drugs work, not on reported cases, but it is still taken seriously. Lumefantrine also stays in your body for several days after you finish it. Please do not stop either medicine on your own. Talk with your pharmacist or doctor. Your care team can choose the safest plan and may check your heart with an .

Mechanism: . Lumefantrine (with artemether) and the class IA antiarrhythmic disopyramide both delay ventricular repolarization, increasing risk of QTc prolongation and .

  • Severity: Major. Evidence: Theoretical. Onset: Unspecified.
  • Management: Avoid . If medically required, monitor the .
  • Lumefantrine has a long (3 to 6 days). Use caution when starting QT-prolonging agents after artemether/lumefantrine is completed.
  • If QT prolongation exceeds 25% with persistent ectopy, monitor closely and consider discontinuing disopyramide.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Disopyramide and Lumefantrine Interact

The likely mechanism


In short: Disopyramide and lumefantrine both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Disopyramide and Lumefantrine Interaction

Care teams usually try to avoid using these two medicines together. If both are truly needed, your team may monitor you more closely with an (heart tracing) to watch your heart rhythm.

  • Keep taking your medicines as prescribed unless your prescriber tells you otherwise.
  • Tell your pharmacist or doctor about every medicine you take, including if you recently finished a malaria treatment, since lumefantrine lingers for several days.
  • Seek care right away for fainting, a racing or fluttering heartbeat, or severe dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Disopyramide or Lumefantrine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Disopyramide and Lumefantrine: Common Questions

How serious is the Disopyramide and Lumefantrine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Disopyramide and Lumefantrine interaction managed?

Care teams usually try to avoid using these two medicines together. If both are truly needed, your team may monitor you more closely with an (heart tracing) to watch your heart rhythm. Keep taking your medicines as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or doctor about every medicine you take, including if you recently finished a malaria treatment, since lu… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Disopyramide and Lumefantrine Interaction

Ask in your own words about taking Disopyramide and Lumefantrine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: NORPACE(R), NORPACE(R) CR oral capsules, extended-release capsules, disopyramide phosphate oral capsules, extended-release capsules. G.D. Searle LLC, Chicago, IL, 2006. DailyMed
  2. Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Was this write-up helpful?

Other Serious Interactions of Disopyramide and Lumefantrine

Also serious with Lumefantrine

Also serious with Disopyramide

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.